Pathogenesis and inflammaging in MDS [MDS Professional Report]
Feb 1, 2025 - 28:47
Radio and PodcastLive Radio & Podcasts![Will Venetoclax Become The New Standard? [MDS Professional Report] artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/7b8bc7d62bbbfefa1a0c2f97a3d163fe.jpg)
Health
Will Venetoclax Become The New Standard? [MDS Professional Report]
We will discuss the addition of venetoclax to hypomethylating agents in the treatment of advanced myeloid neoplasms, especially higher-risk myelodysplastic syndromes.We will then report a study testing the efficacy and s...
Related Episodes
Continue listening to more episodes from MDS Professional Report.
Treatment of lower-risk MDS [MDS Professional Report]
Dec 15, 2024 - 28:57
Treatment for Higher-risk MDS [MDS Professional Report]
Dec 1, 2024 - 28:49
Update on Higher-Risk MDS - Lessons from 2023 ASH [MDS Professional Report]
May 27, 2024 - 21:49
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Mar 27, 2024 - 27:58
Transfusions and quality of life [MDS Professional Report]
May 1, 2023 - 21:49
Bone marrow failure disorders in childhood [MDS Professional Report]
Dec 5, 2022 - 22:31
The role of genetics in MDS management [MDS Professional Report]
Sep 28, 2022 - 22:02